With 1.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.36 million shares. The 52-week range on ERAS shows that it touched its highest point at $3.45 and its lowest point at $1.23 during that stretch. It currently has a 1-year price target of $4.71. Beta for the stock currently stands at 1.12.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ERAS was up-trending over the past week, with a rise of 16.67%, but this was down by -3.14% over a month. Three-month performance dropped to -46.90% while six-month performance fell -46.15%. The stock lost -28.37% in the past year, while it has lost -38.65% so far this year. A look at the trailing 12-month EPS for ERAS yields -0.83 with Next year EPS estimates of -0.59. For the next quarter, that number is -0.12. This implies an EPS growth rate of 12.21% for this year and 19.35% for next year. EPS is expected to grow by 9.17% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -69.36%.
Float and Shares Shorts:
At present, 282.69 million ERAS shares are outstanding with a float of 163.45 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ERAS since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.68873 being high and -$0.83846 being low. For ERAS, this leads to a yearly average estimate of -$0.72866. Based on analyst estimates, the high estimate for the next quarter is -$0.12 and the low estimate is -$0.16. The average estimate for the next quarter is thus -$0.14.
